HRT Financial’s Regulus Therapeutics RGLS Stock Holding History

HRT Financial’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,952	Closed	-$19K	–	3393
2025 Q1	$19K	Buy	+10,952	New	+$14.5K	﹤0.01%	2309
2024 Q2	–	Sell	-62,797	Closed	-$180K	–	2950
2024 Q1	$180K	Buy	+62,797	New	+$102K	﹤0.01%	1796
2022 Q4	–	Sell	-22,735	Closed	-$38K	–	3014
2022 Q3	$38K	Buy	+22,735	New	+$40.9K	﹤0.01%	2458
2015 Q3	–	Sell	-106	Closed	-$139K	–	164
2015 Q2	$139K	Buy	+106	New	+$171K	0.07%	141

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HRT Financial's RGLS Position: Q2 2025 in Review

HRT Financial sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 10,952 shares — an estimated $19K sold.

HRT Financial first reported a position in RGLS in Q2 2015 and held it in 4 quarters. The position peaked at $180K in Q1 2024. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

HRT Financial reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 10,952 Regulus Therapeutics shares in Q2 2025, an estimated $19K.
HRT Financial first reported a position in Regulus Therapeutics in Q2 2015 and held it in 4 quarters.
HRT Financial's Regulus Therapeutics position peaked at $180K in Q1 2024.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.